Current Probiotics—Safety Assured?

Article English OPEN
Salminen, Seppo ; Wright, Atte von (2011)
  • Publisher: Microbial Ecology in Health and Disease
  • Journal: Microbial Ecology in Health and Disease (issn: 1651-2235)
  • Related identifiers: doi: 10.3402/mehd.v10i2.7837

Traditionally probiotics are defined as viable microorganisms (bacteria or yeasts) that have a beneficial effect on the health of the host. Probiotics are used in fermented dairy products, but also in other foods, clinical foods and pharmaceutical preparations and they are also increasingly used as added functional ingredients in non-fermented foods. The selection of new probiotic organisms targets on new strains and even genera that are more beneficial or specific. When totally novel microbes and genetically modified organisms are introduced, their safety and the risk-to-benefit ratio have to be carefully studied and assessed. Also, new probiotics should be of genera and strains commonly found in the healthy human intestinal microflora. Lactic acid bacteria in foods have a long history of safe use. Members of the genera Lactococcus and Lactobacillus are most commonly regarded as having the generally recognised safe status. Members of the genera Streptococcus and Enterococcus and also other genera of lactic acid bacteria include some opportunistic pathogens. The theoretical adverse effects of probiotics including potential acute effects, strain-dependent properties, intrinsic factors and the potential virulence are discussed. The available information supports the safety of currently used probiotics, but recommendations for the safety assessment of new probiotics are needed and proposed.
  • References (74)
    74 references, page 1 of 8

    1. Salminen S, Gibson G, Bouley MC, Isolauri E, BoutronRualt MC, Moreau M-C, Cummings J, Franck A, Rowland I, Roberfroid M. Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80 (Suppl 1): S147 - 71.

    2. Jonas D, Abtignac E, Antoine J-M, Classen H-G, Huggett A, Knudsen I, Mahler J, Ockhuizen T, Smith M, Teuber M, Walker R, de Vogel D. The safety assessment of novel foods. Guidelines prepared by the ILSI Europe novel foods task force. Food Chem Toxicol 1996; 34: 931 - 40.

    3. Hammes WP, Tichaczek PS. The potential of lactic acid bacteria for the production of safe and wholesome food. Z Lebensm Unters Forsch 1994; 198: 193 - 201.

    4. Axelsson L. Lactic acid bacteria: classification and physiology. In: Salminen S, von Wright A, eds. Lactic acid bacteria, microbiology and functional aspects. New York: Marcel Dekker Inc, 1998: 1 - 73.

    5. Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microb 1997; 24: 361 - 4.

    6. Molin G, Jeppson B, Johansson M, Ahrne S, Nobaek S, Stahl M, Bengmark S. Numerical taxonomy of Lactobacillus spp associated with healthy and diseased mucosa of the human intestines. J Appl Bacteriol 1993; 74: 314 - 23.

    7. Lee Y-K, Salminen S. The coming of age of probiotics. Trends Food Sci Techn 1995; 6: 241 - 5.

    8. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Ped Gastroenterol Nutr 1995; 20: 333 - 8.

    9. Salminen S, Isolauri E, Salminen E. Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Anthonie van Leeuwenhoek 1996; 70: 347 - 58.

    10. Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39: 435 - 7.

  • Metrics
    No metrics available
Share - Bookmark